Home / Import refusals / SCS-6494826-9/11/1

FDA Import Refusal SCS-6494826-9/11/1 — Malladi Drugs and Pharmaceuticals Ltd.

Malladi Drugs and Pharmaceuticals Ltd. — FEI 3005115135

The FDA refused shipment SCS-6494826-9/11/1 from Malladi Drugs and Pharmaceuticals Ltd. (India) on September 20, 2019. The refused product falls under Drugs and Biologics — DOXYLAMINE SUCCINATE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 20, 2019
Country
India
Product Category
Drugs and Biologics
Product Code
61XCY21 DOXYLAMINE SUCCINATE (ANTI-HISTAMINIC)
Charges
75

Recent inspections

  • 1191652 (VAI Fri Nov 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1024477 (OAI Fri Sep 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • E46-7006796-3/1/1 (Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • ARV-6004690-6/1/1 (Fri Jan 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 551-1374428-4/1/1 (Wed Dec 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 334-2761257-8/2/1 (Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 334-2761257-8/1/1 (Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources